ICMR Will Get Royalty of 5% from Sale of Bharat Biotech's Covaxin. Here's Why It's Raising Eyebrows
The intellectual property governing the use of Covaxin, jointly developed by Bharat Biotech and the ICMR, was “shared” and that is why it would receive royalty payments.
from Top India News- News18.com https://ift.tt/3fo6oP0
via IFTTT
from Top India News- News18.com https://ift.tt/3fo6oP0
via IFTTT
ليست هناك تعليقات